InsiderTrades

Form 4 for SVRA Savara Inc

Accepted 2023-12-29 00:00:00 ET · period of report 2023-12-28 · accession 0001209191-23-060007 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-12-29 2023-12-28 SVRA Elam Nevan C Dir M - OptEx $1.30 +53.8K 116.3K +86% +$69.7K
D 2023-12-29 2023-12-28 SVRA Elam Nevan C Dir S - Sale+OE $4.71 -93.8K 22.5K -81% -$442.0K
DM 2023-12-29 2023-12-28 SVRA Elam Nevan C Dir M - OptEx $0.00 -53.8K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-28 M A 1,758 $0.82 64,343 D — —
2 Common Common Stock 2023-12-28 M A 12,000 $1.59 76,343 D — —
3 Common Common Stock 2023-12-28 M A 40,000 $1.23 116,343 D — —
4 Common Common Stock 2023-12-28 S D 93,843 $4.71 22,500 D — — (F1) The price is a weighted average sales price. The sale prices ranged from $4.70 to $4.795. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
5 Derivative Stock Option (Right to Buy) 2023-12-28 M D 12,000 $0.00 0 D $1.59 · — to 2029-12-20 12,000 Common Stock (F3) The shares subject to the option vested and became exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019.
6 Derivative Stock Option (Right to Buy) 2023-12-28 M D 40,000 $0.00 0 D $1.23 · — to 2030-12-16 40,000 Common Stock (F4) The shares subject to the option vested and became exercisable on December 16, 2021.
7 Derivative Stock Option (Right to Buy) 2023-12-28 M D 1,758 $0.00 0 D $0.82 · — to 2024-07-24 1,758 Common Stock (F2) The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on October 24, 2014.